Browse Studies — Arctuva

Phase 1

Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (CD40L TIL) for Patients With Oncogene-Driven Advanced Non-Small Cell Lung Cancer (NSCLC)

To determine the effect of a special preparation of cells, called tumor-infiltrating lymphocytes (TIL) stimulated with CD40L, when given with the drug nivoluma…

Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerRecurrent Non Small Cell Lung Cancer

Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT05681780

Observational

Beating Lung Cancer in Ohio (BLCIO) Protocol

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The…

Cigarette SmokerCurrent SmokerLung Adenocarcinoma+2 more

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT03199651

Phase 1

A Phase 1/2, Open-label Study of PD-1 Knockout Tumor-infiltrating Lymphocytes (IOV-4001) in Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced no…

Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more

Estimated

~$10 – $8,750

Iovance Biotherapeutics, Inc.NCT05361174

Observational

Patient-centered, Optimal Integration of Survivorship and Palliative Care

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC…

Stage IV Non-small Cell Lung CancerTargeted TherapyNonsmall Cell Lung Cancer+5 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04900935